Cargando…
Harnessing the immune system in the battle against breast cancer
Breast cancer is the most prevalent malignancy in women and the second most common cause of cancer-related death worldwide. Despite major innovations in early detection and advanced therapeutics, up to 30% of women with node-negative breast cancer and 70% of women with node-positive breast cancer wi...
Autores principales: | Nakasone, Elizabeth S, Hurvitz, Sara A, McCann, Kelly E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810622/ https://www.ncbi.nlm.nih.gov/pubmed/29456568 http://dx.doi.org/10.7573/dic.212520 |
Ejemplares similares
-
Advances in the use of PARP inhibitor therapy for breast cancer
por: McCann, Kelly E, et al.
Publicado: (2018) -
Harnessing genomics in the battle against antimicrobial resistance and neglected tropical diseases
por: Dance, David A.B., et al.
Publicado: (2020) -
Gearing up for battle: Harnessing adaptive T cell immunity against gram-negative pneumonia
por: Gao, Catherine A., et al.
Publicado: (2022) -
The War Is on: The Immune System against Glioblastoma—How Can NK Cells Drive This Battle?
por: da Silva, Lucas Henrique Rodrigues, et al.
Publicado: (2022) -
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
por: Bödder, Johanna, et al.
Publicado: (2021)